Skip to main content
Professional Technical IVT

PGT-M

Also written as: PGT-M — Preimplantation Genetic Testing for Monogenic Disorders

Preimplantation genetic testing for monogenic disorders, testing embryos for specific inherited conditions.

Full Definition

Preimplantation genetic testing for monogenic disorders (PGT-M) is used to test embryos for specific single-gene disorders when one or both parents are known carriers or affected by a genetic condition. Unlike PGT-A which screens for chromosomal abnormalities, PGT-M targets specific mutations such as cystic fibrosis, sickle cell disease, or Huntington's disease. The test requires family-specific probe development and is highly accurate for the targeted condition.

Usage

Usage note: Hyphenate when used as an adjective. Formerly called PGD.

In Context

  • "The couple elected PGT-M testing to avoid transmitting the BRCA1 mutation to their offspring." — Genetic counseling report
  • "PGT-M requires extensive family history and genetic testing before cycle initiation." — Clinical protocol document

Also known as

preimplantation genetic diagnosis PGD

Don't confuse with

PGT-A PGT-SR

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON